When the pandemic hit, we shifted our focus toward sharing inventions – from diagnostics and therapeutics to testing applications to software models and more – that have the potential to impact the COVID-19 crisis.
View Portfolio
At that moment, tech transfer offices around the country pivoted to a humanitarian licensing model for inventions that have the potential to impact the pandemic. AUTM, the professional organization for technology transfer offices, released licensing guidelines to promote broad distribution of such public health solutions by encouraging universities to 1) offer time-limited, non-exclusive, royalty-free licenses to prevent, diagnose, treat and contain the virus during the pandemic; and 2) subsequently convert such non-exclusive licenses to a more typical commercial license, as appropriate. We supported the effort, identified COVID related technologies, and became a signatory to the AUTM licensing guidelines.
We are proud to be part of the greater effort across the Research, Innovation and Impact unit of the UArizona as we all rose to meet the challenge. We highlighted all the efforts around the university, and we looked well beyond our university, joining the XPrize Pandemic Alliance in support of multi-university collaboration efforts.